Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy

Yuichi Oike, Masaki Akao, Yoshiaki Kubota, Toshio Suda

研究成果: Review article査読

105 被引用数 (Scopus)

抄録

Metabolic syndrome is an increasingly prevalent problem, so effective therapeutic approaches to combat it are currently of interest. Recently, orphan ligands with structural similarity to angiopoietins were identified in the systemic circulation, and have been designated angiopoietin-like proteins (Angptls). Angptl3 and Angptl4 have been shown to regulate fat, lipid or glucose metabolic homeostasis. More recently, AGF (also called Angptl6) has been shown to counteract obesity and related insulin resistance. Notably, these factors are secreted mainly from the liver and act as endocrine signals in the peripheral tissues, suggesting a new role for hepatocyte-derived factors in regulating metabolic homeostasis. As more is discovered about the functions of Angptls, so their potential as therapeutic targets for metabolic syndrome is explored.

本文言語English
ページ(範囲)473-479
ページ数7
ジャーナルTrends in Molecular Medicine
11
10
DOI
出版ステータスPublished - 2005

ASJC Scopus subject areas

  • 分子医療
  • 分子生物学

フィンガープリント

「Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル